ELV

Over the past six months, Elevance Health's stock (ELV) has trended upwards, gaining approximately 29.43% to 30.24%. Key events include strong Q2 2026 earnings that beat expectations and led to raised guidance, positive analyst sentiment resulting in upgraded ratings and increased price targets, and strategic initiatives for Medicare Advantage and cost control. The stock also benefited from the general resilience of the healthcare sector. However, it faced regulatory pressure from CMS regarding Medicare Advantage enrollment and a shareholder lawsuit concerning Medicaid cost disclosures.